Cargando…

Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST‐CHF study

AIMS: Chronic heart failure (HF) is a common disease and one of the leading causes of death worldwide. Heart failure with preserved ejection fraction (HFpEF) and with reduced ejection fraction (HFrEF) are different diseases with distinct as well as comparable pathophysiologies and diverse responses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eidizadeh, Abass, Schnelle, Moritz, Leha, Andreas, Edelmann, Frank, Nolte, Kathleen, Werhahn, Stefanie Maria, Binder, Lutz, Wachter, Rolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871664/ https://www.ncbi.nlm.nih.gov/pubmed/36184749 http://dx.doi.org/10.1002/ehf2.14167

Ejemplares similares

Determinants of submaximal exercise capacity in patients at risk for heart failure with preserved ejection fraction—results from the DIAST‐CHF study
por: Stahrenberg, Raoul, et al.
Publicado: (2015)

The diagnostic and prognostic value of galectin‐3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST‐CHF study
por: Trippel, Tobias Daniel, et al.
Publicado: (2021)

Evaluation of the HFA‐PEFF Score: results from the prospective DIAST‐CHF cohort
por: Hashemi, Djawid, et al.
Publicado: (2022)

Plasma Biomarker Profiling in Heart Failure Patients with Preserved Ejection Fraction before and after Spironolactone Treatment: Results from the Aldo-DHF Trial
por: Schnelle, Moritz, et al.
Publicado: (2021)

Elevated Plasma C-Terminal Endothelin-1 Precursor Fragment Concentrations Are Associated with Less Anxiety in Patients with Cardiovascular Risk Factors. Results from the Observational DIAST-CHF Study
por: Meyer, Thomas, et al.
Publicado: (2015)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Inconsistent Findings of Cardiac Troponin T and I in Clinical Routine Diagnostics: Factors of Influence
por: Eidizadeh, Abass, et al.
Publicado: (2021)

Comparison of a novel automated DiaSys procalcitonin immunoassay with four different BRAHMS-partnered immunoassays
por: Eidizadeh, Abass, et al.
Publicado: (2022)

Outcome assessment using estimation of left ventricular filling pressure in asymptomatic patients at risk for heart failure with preserved ejection fraction
por: Bobenko, Anna, et al.
Publicado: (2020)

Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction
por: Nolte, Kathleen, et al.
Publicado: (2019)

Influence of baseline parameters on one‐year physical, mental, and health‐related quality of life in patients with heart failure and preserved ejection fraction
por: Fitz, Judith, et al.
Publicado: (2021)

Heterogeneous Metabolic Response to Exercise Training in Heart Failure with Preserved Ejection Fraction
por: Bahls, Martin, et al.
Publicado: (2019)

Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction
por: Bobenko, Anna, et al.
Publicado: (2017)

Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial
por: Hashemi, Djawid, et al.
Publicado: (2020)

The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction
por: Stahrenberg, Raoul, et al.
Publicado: (2010)

Suppression of Tumourigenicity 2 in Heart Failure With Preserved Ejection Fraction
por: Zach, Veronika, et al.
Publicado: (2020)

Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction
por: Edelmann, Frank, et al.
Publicado: (2011)

Facts and numbers on epidemiology and pharmacological treatment of heart failure with preserved ejection fraction
por: Edelmann, Frank
Publicado: (2015)

Ghrelin and hormonal markers under exercise training in patients with heart failure with preserved ejection fraction: results from the Ex‐DHF pilot study
por: Trippel, Tobias Daniel, et al.
Publicado: (2016)

Treatment response to spironolactone in patients with heart failure with preserved ejection fraction: a machine learning-based analysis of two randomized controlled trials
por: Kresoja, Karl-Patrik, et al.
Publicado: (2023)

The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction
por: Kintscher, Ulrich, et al.
Publicado: (2023)

Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction
por: Luo, Nancy, et al.
Publicado: (2021)

Heart Failure With Preserved Ejection Fraction vs. Reduced Ejection Fraction　― Mechanisms of Ventilatory Inefficiency During Exercise in Heart Failure ―
por: Tsujinaga, Shingo, et al.
Publicado: (2020)

Large Animal Models of Heart Failure: Reduced vs. Preserved Ejection Fraction
por: Charles, Christopher J., et al.
Publicado: (2020)

Respiratory support in acute heart failure with preserved vs reduced ejection fraction
por: Metkus, Thomas S., et al.
Publicado: (2019)

Gender-related differences in heart failure with preserved ejection fraction
por: Duca, Franz, et al.
Publicado: (2018)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction
por: Hamada, Tomoyuki, et al.
Publicado: (2022)

Outcome of angiotensin receptor-neprilysin inhibitor on anxiety and depression in heart failure with reduced ejection fraction vs. heart failure with preserved ejection fraction
por: Malik, Jahanzeb, et al.
Publicado: (2021)

Glucose-Induced Hemodynamic and Metabolic Response of Skeletal Muscle in Heart Failure Patients with Reduced vs. Preserved Ejection Fraction—A Pilot Study
por: Boschmann, Michael, et al.
Publicado: (2022)

Patients with Heart Failure and Preserved Ejection Fraction Are at Risk of Gastrointestinal Bleeding
por: Schrutka, Lore, et al.
Publicado: (2019)

Comparison of haemodynamic response to muscle reflex in heart failure with reduced vs. preserved ejection fraction
por: Moriwaki, Keishi, et al.
Publicado: (2021)

Cardiometabolic Phenotyping in Heart Failure: Differences between Patients with Reduced vs. Preserved Ejection Fraction
por: Balletti, Alessio, et al.
Publicado: (2023)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Predictors of Unfavorable Outcomes in Patients with Atrial Fibrillation and Concomitant Heart Failure with Different Ejection Fractions: RIF-CHF Register One-Year Follow-Up
por: Zhirov, Igor, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rpo3im4gu08oq9kr86lfb95160